Thrombocytopenia
269 results
1 - 100
Thrombocytopenia 
LMWH = UFH for thrombocytopenia
Antenatal interventions for fetomaternal alloimmune thrombocytopenia- Comparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopenia
- Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia
- Unfractionated heparin versus low molecular weight heparins for avoiding heparin‐induced thrombocytopenia in postoperative patients
- Thrombopoietin receptor agonists for prevention and treatment of chemotherapy-induced thrombocytopenia in patients with solid tumours: Cochrane systematic review
- Risk for heparin-induced thrombocytopenia (HIT) with either low-molecular-weight heparin (LMWH) or unfractionated heparin (UFH)
- Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta‐analysis and systematic review
- Blood count changes in children (leucocytes and platelets)
- Prevention of venous thromboembolism
- Adverse effects of antineoplastic agents
- Easy bruising, petechiae and ecchymoses
- Epidemic nephropathy
- Romiplostim safe, effective, and very expensive treatment for ITP
- Cholesterol embolization
- Assessment and treatment of a patient with bleeding diathesis
- Diagnosis and treatment of malaria
- Long-term adverse effects of antineoplastic agents
- Withholding platelet transfusion from thrombocytopenic patients with central venous catheters = more bleeding events
- Linezolid no better than vancomycin for treatment of nosocomial pneumonia
- Medical treatments for idiopathic thrombocytopenic purpura during pregnancy: Cochrane systematic review
- Eating disorders among children and adolescents
- Oncological emergencies
- Myelodysplastic syndromes (MDS)
- Multiple myeloma (MM)
- Acute leukaemias in adults
- IgA vasculitis (Henoch-Schönlein purpura) - Image
- Management of adverse effects of radiotherapy
- Megaloblastic anaemia
- Blood transfusion: indications, administration and adverse reactions
- Mixed connective tissue disease (MCTD)
- Thrombocytosis
- Bone marrow examination
- Antithrombotic agents in primary health care
- Bruises and purpura in children
- Systemic treatments for the prevention of venous thrombo‐embolic events in paediatric cancer patients with tunnelled central venous catheters
- Prophylactic platelet transfusions prior to surgery for people with a low platelet count
- Thrombopoietin mimetics for patients with myelodysplastic syndromes: Cochrane systematic review
- Chronic lymphocytic leukaemia (CLL)
- Heparin-bonded catheters for prolonging the patency of central venous catheters in children: Cochrane systematic review
- Early intravenous nutrition for the prevention of neonatal jaundice
- Autoimmune hepatitis
- Anticoagulation for the initial treatment of venous thromboembolism in people with cancer
- Waldenström's macroglobulinaemia (WM)
- Systemic lupus erythematosus (SLE)
- Exanthem (eruptive skin rash)
- Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders: Cochrane systematic review
- Multisystem inflammatory syndrome in children (MIS-C) with COVID-19 infection
- Antitubercular medication in ambulatory care
- Disease-specific signs and symptoms in patients with inflammatory joint diseases
- Cyclophosphamide for treating rheumatoid arthritis
- Interferon-alpha therapy for chronic hepatitis B in children
- Severe infections of the skin and soft tissues
- Anticoagulation for perioperative thromboprophylaxis in people with cancer